Thus, PPAR‐α agonist FN enhances synaptic plasticity in male but not in female mice [79], suggesting a sexual dimorphism in response to PPAR‐α agonists in AD management, and this may explain a higher AD risk in women [81]. The gene discussed is PPARA; the disease is Alzheimer disease.